LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Pricing of HPV Vaccines in Europe: Back to the Future?

Photo from archive.org

Human papilloma viruses (HPV) can cause sexually transmitted infections, which in some cases persist and progress to cancer. Among the 201 HPV genotypes so far identified, more than 40 have… Click to show full abstract

Human papilloma viruses (HPV) can cause sexually transmitted infections, which in some cases persist and progress to cancer. Among the 201 HPV genotypes so far identified, more than 40 have been classified as highand low-risk types according to their risk of progression to cancer [1]. Cervical cancer (CC) is the second most common cancer in women worldwide (about 55,000 new cases every year in Europe), and almost 100% of these are caused by HPV infection [2], which is also associated with other much less frequent cancers such as anal (around 90% of cases related to HPV in Europe), vulvar (15%), vaginal (70%), and penile (30–40%) cancers. Finally, HPV infection causes benign lesions such as genital warts (GWs) and recurrent respiratory papillomatosis (RRPs).

Keywords: pricing hpv; vaccines europe; hpv vaccines; hpv; europe back; cancer

Journal Title: Applied Health Economics and Health Policy
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.